Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.44
Delayed Data
As of Apr 29
 +0.18 / +3.42%
Today’s Change
2.80
Today|||52-Week Range
11.40
+7.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Operating ActivitiesNet Income / Starting Line-27.7M-26.9M-30.7M-37.8M
 
 
 
 
 
Depreciation138.0K145.0K148.0K165.0K
 
 
 
 
 
Total Other Cash Flow4.3M4.0M4.5M17.7M
 
 
 
 
 
Funds From Operations-23.3M-22.7M-26.1M-19.9M
 
 
 
 
 
Funds From/For Other Operating Expenses12.0M15.3M2.8M4.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-35.3M-38.0M-28.8M-24.6M
 
 
 
 
 
 
InvestingDecrease In Investments11.5M0.000.000.00
 
 
Capital Expenditures-61.0K-103.0K-268.0K-2.3M
 
 
 
 
 
Net Cash Flow Investing11.4M-103.0K-268.0K-2.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00125.0M
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale126.6M-6.9M9.0K16.0K
 
 
 
 
 
Common Preferred Redeemed-8.2M8.2M0.000.00
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.0015.0K0.000.00
 
 
Net Cash Flow - Financing118.4M1.3M9.0K125.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.00----
 
Net Change In Cash94.6M-36.7M-29.1M98.1M